← Leaderboards
Michelle A. Barron
University Of Colorado Denver
$14,795
Attributed
$14,795
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.4K · FY2007–08$20K$15K$10K$5K$0
'07
'08
Funding mix
By agency
NIH$14,795 · 2
By mechanism
M01$14,795 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Elizabeth Connick$17,363,459
- Mamuka Kvaratskhelia$22,358,187
- Thomas A Campbell$2,616,890
- Robert Turner Schooley$73,100,957
- Elizabeth J Shpall$12,617,686
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAdverse EffectsAnti-Hiv AgentsAnti-Retroviral AgentsBloodChronicComputer Retrieval Of Information On Scientific Projects DatabaseDrug UsageFundingGrantHiv InfectionsImmune SystemInstitutionLearningLopinavirLopinavir/RitonavirMedicinePharmaceutical PreparationsResearch PersonnelResourcesRitonavirSourceTenofovirTruvada